An antimicrobial can be described as a natural, semi-synthetic, or synthetic substance that kills or inhibits most microorganisms but causes little or no loss to the host. All antibiotics are antimicrobials; however, not all antimicrobials are antibiotics. Antimicrobial products have remarkable food safety benefits for both animals and humans. Veterinary antibiotics can be used in animals and can contribute to the spread of antibiotic resistance in bacteria that can be transmitted to humans; henceforth, it decreases the effectiveness of antimicrobial drugs used to treat human diseases.

There are studies that have shown that an increase in the rate of disease in animals leads to a higher rate of disease in humans. Therefore, livestock traders rely on animal antibiotics to deliver safe food. Antimicrobial and antibiotic treatments for animals are sold to various end-use segments such as dairy market, animal meat market, pet market, livestock market and animal feed market.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as acquisition is expected to drive market growth over the forecast period. For instance, in August 2020, Elanco Animal Health Incorporated, a global leader in animal health announced the acquisition of Bayer Animal Health. The companies had signed a definitive agreement to acquire and transaction was completed after fulfillment of the closing conditions, including the receipt of regulatory approvals. This agreement will help in the expansion of Elanco's portfolio of leading global brands and strengthens its innovation capabilities and R&D pipeline.

Key features of the study:

• This report provides an in-depth analysis of the global veterinary antibiotics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary antibiotics market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Virbac, and Zoetis, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market

Detailed Segmentation:

• Global Veterinary Antibiotics Market, By Product Type:
  • Anti-parasitic
  • Anti-bacterial
  • Non-steroidal anti-inflammatory drug
  • Others
• Global Veterinary Antibiotics Market, By End-use:
  • Dairy Farm
  • Poultry Farm
  • Others
• Global Veterinary Antibiotics Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Bayer AG
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale S.A.
  • Crystal Pharma
  • Dechra Pharmaceuticals PLC
  • Huvepharma AD
  • Eli Lilly Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Vetoquinol S.A.
  • Virbac
  • Zoetis, Inc.

“*” marked represents similar segmentation in other categories in the respective section.